Apricus' Partner Recordati Launches Vitaros In Portugal, Ireland And Poland

(RTTNews) - Apricus Biosciences, Inc. (APRI) Tuesday announced the launch of Vitaros, an on-demand topical cream for the treatment of erectile dysfunction or ED in Portugal, Ireland and Poland by its partner Recordati.

Vitaros is now commercially available in seven European countries, including Spain. The company expects to obtain FDA approval for Vitaros in the United States in 2017.

Under the terms of the agreement, Apricus is eligible to receive up to approximately $39.7 million from Recordati in additional milestones in addition to $2.4 million received in 2014 at the time of exclusive license agreement.